Long QT Syndrome screening: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) No edit summary |
Farima Kahe (talk | contribs) |
||
Line 14: | Line 14: | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | ||
==Screening== | ==Screening== | ||
Screening for long QT syndrome by ECG is recommended every [duration] among patients with: | |||
*First afebrile, generalized seizure | |||
*Unexplained syncope | |||
*Syncopal episode has beeN consistent with neurocardiogenic (vasovagal) syncope | |||
==References== | ==References== | ||
Latest revision as of 16:54, 25 March 2020
Long QT Syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Long QT Syndrome screening On the Web |
American Roentgen Ray Society Images of Long QT Syndrome screening |
Risk calculators and risk factors for Long QT Syndrome screening |
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
Screening for long QT syndrome by ECG is recommended every [duration] among patients with:
- First afebrile, generalized seizure
- Unexplained syncope
- Syncopal episode has beeN consistent with neurocardiogenic (vasovagal) syncope